Catherine Smith, MD retweeted
Getting ready to present “State of the laboratory” talk today at lab meeting. This allows me to not only describe the kinds of projects we are working on, but also previous work that has led to where we are today. It helps me to formulate future plans & share a mission statement.
Catherine Smith, MD retweeted
Sad for people like me, who work in public health, #healthequity interventions & #implementation science watch good, competent people flail at delivery of #COVID19 vaccines. They know how to work within the #healthcare system but don’t realize it’s broken nitter.gq/CNN/status/13526316196…
About 6 in 10 Americans don't know when or where to get a coronavirus vaccine, according to a survey from the Kaiser Family Foundation. cnn.it/2MhsSW9
Catherine Smith, MD retweeted
Our Leukemia Program @DanaFarber has an open search for a clinical investigator position. Please pass on: careercenter.asco.org/job/76…
Catherine Smith, MD retweeted
Congrats @vekennedy on being named a @czbiohub Physician Scientist Fellow! #WomenInSTEM #WomenInMedicine
Catherine Smith, MD retweeted
The inclusion of this study in #ASHPlenary shows the commitment of @ASH_hematology to #DiversityandInclusion and addressing #HealthDisparities
"Poor Treatment Outcomes of Young (<60 Years) African American Patients (Pts) Diagnosed with Acute Myeloid Leukemia"
#ASH20 #ASHKudos
Catherine Smith, MD retweeted
#ASH20 #ASHKudos in #ASHPlenary session to commentary and introduction by Dr Chancellor Donald, MD | 🙏 for inspiring important words about work needed #PersistentHealthCareDisparities #RaceInMedicine #ImprovingOutcomes #AuthenticIntention @StephanieLeeMD @ASH_hematology
Catherine Smith, MD retweeted
Wow, this intro by #ChancellorDonald is EVERYTHING. Thank you @ASH_hematology for using your platform to address health disparities. #ASH20
Catherine Smith, MD retweeted
The introduction of this talk by Dr. Chancellor Donald was inspirational- his call to be intentional in recognizing the reasons for these disparities really hit home. #ASH20 #leusm
See below for upcoming Plenary talk about disparities and different outcomes associations in young AA pts by @BhavanaBhatnag4 @AkEisfeld @ALLIANCE_org and published paper in @CD_AACR ! Such important issues that affect our AML patients! @ASH_hematology #ASH20
Catherine Smith, MD retweeted
#ASH20 #leusm | AML oral session. Dr Yngvar Floisand, Norway 🇳🇴 Very nice talk on novel #Vaccine 💉 strategy in patients with R/R AML | #WT1 #PRAME #DCvaccine #FastDC #ImmunoOnc | Fantastic international involvement in our session speakers/moderators #ASHKudos @ASH_hematology
Catherine Smith, MD retweeted
So lucky to be surrounded by amazing women at work. I spend so much time there ....I gotta love my peeps!! @ROlinMD @SandyWong02111 @UCSFCancer @TomBmt133
Catherine Smith, MD retweeted
Five women on the #myeloma panel this morning co-led by @ninashah33 .As said often during this #ASH19 we are blessed in our field with great #WoMMen to lead #mmsm research into the 3rd decade of the 21st century. Thank you @IreneGhobrial @mvmateos @NoopurRajeMD and so many others
Catherine Smith, MD retweeted
Excited to share our new story in @nature on coordinated effects of alterations in RNA splicing and the epigenome in AML patients!
nature.com/articles/s41586-0…
Catherine Smith, MD retweeted
What Are the Treatment Implications Now that We Can See Tumor Heterogeneity? We Ask Cathy Smith, @UCSF buff.ly/2LVZnFD
@SmithLabUCSF #singlecellgenomics #cancergenomics #AML
Catherine Smith, MD retweeted
Clonal selection with #RAS pathway activation mediates secondary clinical #resistance to selective #FLT3 inhibition with #gilteritinib in acute myeloid #leukemia.
@PennMedicine @PennCancer
https://nitter.gq/t.co/HVXFuPWYOj




























